Halozyme Therapeutics' (HALO) Price Target Raised to $21 at JMP

June 4, 2015 8:23 AM

JMP Securities maintained a Market Outperform rating on Halozyme Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found